Prostate Cancer - Results from #28540

Robotic image-guided stereotactic radiotherapy, for isolated recurrent primary, lymph node or metastatic prostate cancer - Abstract March 3, 2011

To screen or not to screen: Ongoing debate in the early detection of prostate cancer - Abstract March 3, 2011

Screening for prostate cancer: Growth without control - Abstract March 3, 2011

Docetaxel and epirubicin compared with docetaxel and prednisone in advanced castrate-resistant prostate cancer: A randomised phase II study - Abstract March 3, 2011

GU Cancers Symposium 2011: ASCO ASTRO SUO - The impact of comorbidity on survival among men with localized prostate cancer - Session Highlights March 3, 2011

GU Cancers Symposium 2011: ASCO ASTRO SUO - PSA response and early PSA progression evaluated in patients randomized in a phase III trial... March 3, 2011

Scientists target aggressive prostate cancer March 3, 2011

Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy - Abstract March 2, 2011

Endorectal MRI accuracy in auguring tumour location, tumour extent, capsular perforation and seminal vesicle invasion of prostate cancer in North-African men - Abstract March 2, 2011

The effect of supplemental vitamins and minerals on the development of prostate cancer: A systematic review and meta-analysis - Abstract March 2, 2011

Information for decision making by patients with early-stage prostate cancer: A comparison across 9 countries - Abstract March 2, 2011

Racial differences in well-being and cancer concerns in prostate cancer patients - Abstract March 2, 2011

Oral/metronomic cyclophosphamide-based chemotherapy as option for patients with castration-refractory prostate cancer - Review of the literature - Abstract March 2, 2011

GU Cancers Symposium 2011: ASCO ASTRO SUO - Using Gleason pattern 5 to refine risk stratification for prostate cancer patients treated with dose-escalated radiotherapy and androgen deprivation therapy - Session Highlights March 2, 2011

GU Cancers Symposium 2011: ASCO ASTRO SUO - Role of traditional and modern hormone therapy for biochemical failures after local therapy - Session Highlights March 2, 2011

Impact of adjuvant androgen deprivation therapy after radical prostatectomy on the survival of patients with pathological T3b prostate cancer - Abstract March 1, 2011

Prognostic impact of abdominal adiposity, waist circumference and body mass index in patients with intermediate-risk prostate cancer treated with radiotherapy - Abstract March 1, 2011

Association of obesity with prostate cancer: A case-control study within the population-based PSA testing phase of the ProtecT study - Abstract March 1, 2011

Obese frailty, physical performance deficits, and falls in older men with biochemical recurrence of prostate cancer on androgen deprivation therapy: A case-control study - Abstract March 1, 2011

ACR appropriateness criteria postradical prostatectomy irradiation in prostate cancer - Abstract March 1, 2011

Page 1428 of 1437